Research Progress on Cardiotoxicity of PD-1/PD-L1 Immune Checkpoint Inhibitors / 肿瘤防治研究
Cancer Research on Prevention and Treatment
;
(12): 794-798, 2021.
Article
in Chinese
| WPRIM
| ID: wpr-988450
ABSTRACT
Cardiotoxicity is a serious complication of antineoplastic drugs. With the continuous development of antineoplastic drugs, immune checkpoint inhibitors have been used in the treatment of a variety of cancers. PD-1/PD-L1 immune checkpoint inhibitors have been widely concerned in recent years. This article reviews the manifestations and possible mechanisms of cardiotoxicity induced by PD-1/PD-L1 immune checkpoint inhibitors, and the detection methods and treatment of cardiotoxicity.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Cancer Research on Prevention and Treatment
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS